genesis digital currency group Top Overview

CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.Gobi Venture Capital announced in Shanghai that it will launch a $50 million venture capital fund to support Pakistan's technology start-ups. On December 12th, at the Pakistan Investment Summit held in Shanghai, Gobi Venture Capital, an Asian venture capital company, officially announced the launch of a $50 million fund Techxila Fund II to support Pakistan's start-ups, focusing on high-potential industries such as financial technology, e-commerce logistics and supply chain, health technology and SaaS. Gobi Venture Capital also signed a memorandum of understanding with Punjab Bank (BoP). (First Financial Reporter Qian Tongxin)Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.

The Southern CSI A500ETF Link Fund was added with Y share, which was included in the list of individual pensions. Four products from southern fund were shortlisted for individual pensions, including the Southern CSI A500ETF Link Fund, and Y share was added with code 022918. Its target ETF-CSI A500ETF South (159352) has received a net inflow of funds for 38 consecutive days, with the latest scale approaching 19 billion yuan. According to the data of China Merchants Securities Fund Evaluation Center, in the past 10 years, South Stock ETF has been the most accurate in tracking, ranking first in its kind. Investors can borrow the layout of the A500ETF South (159352) and its linked funds (A 022434, C 022435, Y 022918).AIA Group repurchased 1.1 million shares for HK$ 61.7 million on December 12th.Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.

The US dollar just hit the 7.2700 yuan mark against the offshore RMB, and the latest price was 7.2700 yuan, down 0.10% in the day. The US dollar against the onshore RMB was recently reported at 7.2660 yuan, up 0.06% in the day.Industrial Securities' investment strategy for the construction industry in 2025: internal and external resonance, optimistic about debt conversion and the "Belt and Road" industry, Industrial Securities Research Report said that the construction industry will face certain pressure in 2024, and it is expected that infrastructure investment will remain high in 2025, driven by the debt conversion policy. Review and prospect of plate market: central state-owned enterprises and design plates led the gains, with obvious excess returns. Main line 1: Debt conversion is expected to drive the improvement of the management quality of construction central enterprises. 1) The driving force and mode of action of this debt conversion can be compared with the "Belt and Road" market in 2014 and the PPP market in 2016, and the policy is driven from top to bottom. 2) The institutions' positions in construction central enterprises are low, and the valuation of construction central enterprises is also in the lower position of the historical center. 3) The unprecedented intensity of debt conversion will help the central enterprises to realize the double promotion of EPS and PE. Main Line 2: The Belt and Road Initiative is expected to accelerate and benefit international engineering enterprises. The "Belt and Road" market has accelerated its expansion, and international engineering enterprises are expected to accelerate their going out to sea, and their performance and valuation have both improved.